A ‘fit’ microbiota to potentiate cancer immunotherapy

Cancer immunotherapy is very effective and leads to a long-term response in certain patients. Yet, the variability observed in this response indicates that additional factors related to the host must influence the activity of the treatments. Recent research suggests that the microbiota might play an...

Descripción completa

Detalles Bibliográficos
Autor principal: Rescigno, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687315/
https://www.ncbi.nlm.nih.gov/pubmed/26689196
http://dx.doi.org/10.1186/s13073-015-0256-x
_version_ 1782406610667175936
author Rescigno, Maria
author_facet Rescigno, Maria
author_sort Rescigno, Maria
collection PubMed
description Cancer immunotherapy is very effective and leads to a long-term response in certain patients. Yet, the variability observed in this response indicates that additional factors related to the host must influence the activity of the treatments. Recent research suggests that the microbiota might play an important part in this variability.
format Online
Article
Text
id pubmed-4687315
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46873152015-12-23 A ‘fit’ microbiota to potentiate cancer immunotherapy Rescigno, Maria Genome Med Research Highlight Cancer immunotherapy is very effective and leads to a long-term response in certain patients. Yet, the variability observed in this response indicates that additional factors related to the host must influence the activity of the treatments. Recent research suggests that the microbiota might play an important part in this variability. BioMed Central 2015-12-21 /pmc/articles/PMC4687315/ /pubmed/26689196 http://dx.doi.org/10.1186/s13073-015-0256-x Text en © Rescigno. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Highlight
Rescigno, Maria
A ‘fit’ microbiota to potentiate cancer immunotherapy
title A ‘fit’ microbiota to potentiate cancer immunotherapy
title_full A ‘fit’ microbiota to potentiate cancer immunotherapy
title_fullStr A ‘fit’ microbiota to potentiate cancer immunotherapy
title_full_unstemmed A ‘fit’ microbiota to potentiate cancer immunotherapy
title_short A ‘fit’ microbiota to potentiate cancer immunotherapy
title_sort ‘fit’ microbiota to potentiate cancer immunotherapy
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687315/
https://www.ncbi.nlm.nih.gov/pubmed/26689196
http://dx.doi.org/10.1186/s13073-015-0256-x
work_keys_str_mv AT rescignomaria afitmicrobiotatopotentiatecancerimmunotherapy
AT rescignomaria fitmicrobiotatopotentiatecancerimmunotherapy

Ejemplares similares